Bedel Financial Consulting’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-173
Closed 967
2022
Q1
$0 Hold
173
﹤0.01% 1091
2021
Q4
$0 Hold
173
﹤0.01% 1099
2021
Q3
$0 Hold
173
﹤0.01% 1041
2021
Q2
$1K Hold
173
﹤0.01% 951
2021
Q1
$1K Buy
+173
New +$627 ﹤0.01% 915
2019
Q2
Sell
-46
Closed -$1K 755
2019
Q1
$1K Hold
46
﹤0.01% 691
2018
Q4
$1K Hold
46
﹤0.01% 665
2018
Q3
$2K Buy
+46
New +$3.11K ﹤0.01% 630

Other funds holding ASXC

Bedel Financial Consulting's ASXC Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 173 shares.

Bedel Financial Consulting first reported a position in ASXC in Q3 2018 and held it in 8 quarters. The position peaked at $2K in Q3 2018. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 173 Asensus Surgical, Inc. shares in Q2 2022.
  • Bedel Financial Consulting first reported a position in Asensus Surgical, Inc. in Q3 2018 and held it in 8 quarters.
  • Bedel Financial Consulting's Asensus Surgical, Inc. position peaked at $2K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.